Dupont Capital Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-14,475
Closed -$938K 982
2017
Q3
$938K Hold
14,475
0.02% 534
2017
Q2
$783K Hold
14,475
0.02% 575
2017
Q1
$808K Hold
14,475
0.02% 574
2016
Q4
$712K Hold
14,475
0.02% 580
2016
Q3
$868K Hold
14,475
0.02% 486
2016
Q2
$506K Hold
14,475
0.01% 577
2016
Q1
$596K Buy
14,475
+9,596
+197% +$376K 0.01% 520
2015
Q4
$332K Buy
+4,879
New +$294K 0.01% 609

Other funds holding PRTA

Dupont Capital Management's PRTA Position: Q4 2017 in Review

Dupont Capital Management sold out of Prothena Corp (PRTA) in Q4 2017, closing a stake of 14,475 shares — an estimated $938K sold.

Dupont Capital Management first reported a position in PRTA in Q4 2015 and held it in 8 quarters. The position peaked at $938K in Q3 2017. 155 funds tracked by Wall St. Rank hold PRTA as of Q4 2017.

  • Dupont Capital Management reported no remaining Prothena Corp position as of Q4 2017 after selling out during the quarter.
  • Dupont Capital Management sold 14,475 Prothena Corp shares in Q4 2017, an estimated $938K.
  • Dupont Capital Management first reported a position in Prothena Corp in Q4 2015 and held it in 8 quarters.
  • Dupont Capital Management's Prothena Corp position peaked at $938K in Q3 2017.
  • 155 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2017.

Based on Dupont Capital Management's 13F filing for Q4 2017, filed 31 Jan 2018.